Latest filing published 08 Oct 2025 for Verona Pharma plc. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Mahendra Shah, listed as board member, appears in our data through filings on Verona Pharma plc shares, published by SEC (Form 4). Between 4 May 2021 and 7 October 2025, the trades on record add up to 3 filings.
Every open-market trade on record is a sale: 1 sale worth €7,464. Outside the open market, there are 1 option exercise.
Most recently, on 8 October 2025, the filings show a transaction in Verona Pharma plc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations